Reported a net income of $1.7 million, or $0.04 per diluted common share, for Q3 2024.
Key Takeaways
Community Healthcare Trust reported a net income of $1.7 million, or $0.04 per diluted common share, for the three months ended September 30, 2024. FFO was $0.48 per diluted common share and AFFO was $0.55 per diluted common share.
Acquired one physician clinic for approximately $6.2 million.
Disposed of a surgical center in Texas for net proceeds of approximately $1.0 million.
Entered into a second Amendment to the third amended and restated credit agreement, increasing the Revolving Credit Facility from $150.0 million to $400.0 million and extending the maturity date to October 16, 2029.
Declared a quarterly common stock dividend of $0.465 per share.
The Company has four properties under definitive purchase agreements for an aggregate expected purchase price of approximately $8.8 million. The Company also has seven properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $169.5 million.
Positive Outlook
Expected returns on the $8.8 million investments range from 9.29% to 9.50%.
Expected returns on the $169.5 million investments are approximately 9.1% to 9.75%.
The Company expects to close on the properties in the fourth quarter of 2024.
Anticipates closing on the other properties throughout 2025, 2026 and 2027.
Increased the Company's Revolving Credit Facility from $150.0 million to $400.0 million, extended the maturity date of the Revolving Credit Facility from March 19, 2026 to October 16, 2029, and lowered pricing on the Revolving Credit Facility by 10 to 30 basis points, depending on the Company's leverage ratio.
Challenges Ahead
The Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Real estate values have historically risen or fallen with market conditions.
General volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, the conflicts in Ukraine and the Middle East, and/or uncertainties related to the 2024 U.S. presidential election, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and the Company’s other filings with the Securities and Exchange Commission from time to time.
FFO and AFFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company’s liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company’s needs.
The Company’s actual results and financial condition may differ materially from those indicated in forward-looking statements.
